Jul 31, 2017 20:15 pm UTC| Business
Reports multiple recent developments and milestones Plans to report top-line results from the second monotherapy dosing cohort of the ACHIEVE global Phase 2 clinical trial of SB 9200 in chronic HBV in 4Q 2017 Successful...
Orchid Island Capital Announces Second Quarter 2017 Results
Jul 31, 2017 20:15 pm UTC| Business
VERO BEACH, Fla., July 31, 2017 -- Orchid Island Capital, Inc. (NYSE:ORC) ("Orchid” or the "Company"), a real estate investment trust ("REIT"), today announced results of operations for the three month period ended June...
Blue Capital Reinsurance Holdings Reports Second Quarter 2017 Financial Results
Jul 31, 2017 20:15 pm UTC| Business
HAMILTON, Bermuda, July 31, 2017 -- Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH) ("Blue Capital"), a Bermuda holding company that, through its operating subsidiaries, offers collateralized reinsurance in the...
Proteostasis Appoints Helen M. Boudreau as Chief Financial Officer
Jul 31, 2017 20:15 pm UTC| Business
CAMBRIDGE, Mass., July 31, 2017 -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing such as...
Jul 31, 2017 20:15 pm UTC| Business
MARION, N.Y., July 31, 2017 -- Seneca Foods Corporation (NASDAQ:SENEA) (NASDAQ:SENEB) today announced financial results for the first quarter ended July 1, 2017. Highlights (vs. year-ago, first quarter results): Net...
Jul 31, 2017 20:15 pm UTC| Business
GAITHERSBURG, Md., July 31, 2017 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded approximately $23 million to develop a novel multi-drug auto-injector for nerve agent antidote delivery....
Jul 31, 2017 20:15 pm UTC| Business
RAMSEY, N.J. and BOCA RATON, Fla., July 31, 2017 -- ADMA Biologics, Inc. (NASDAQ:ADMA) is a vertically integrated biopharmaceutical and specialty immunoglobulin company that develops, manufactures and commercializes...